Cargando…

Differentiated regulation of immune-response related genes between LUAD and LUSC subtypes of lung cancers

Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) are the two major subtypes of lung cancer, with LUSC exhibits faster progression rate than LUAD. To investigate the roles of immune-response related genes (IRGs) in lung cancer progression, we used LUAD and LUSC samples at different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mengzhu, Liu, Xiuying, Du, Jie, Wang, Xiu-Jie, Xia, Lixin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352059/ https://www.ncbi.nlm.nih.gov/pubmed/27863400 http://dx.doi.org/10.18632/oncotarget.13346

Ejemplares similares

Identification of the key genes and characterizations of Tumor Immune Microenvironment in Lung Adenocarcinoma (LUAD) and Lung Squamous Cell Carcinoma (LUSC)
por: Zhang, Lemeng, et al.
Publicado: (2020)

Construction and validation of a cuproptosis-related lncRNA signature for the prediction of the prognosis of LUAD and LUSC
por: Wang, Yu, et al.
Publicado: (2023)

The value of CEP55 gene as a diagnostic biomarker and independent prognostic factor in LUAD and LUSC
por: Fu, Linhai, et al.
Publicado: (2020)

In silico assessment of EpCAM transcriptional expression and determination of the prognostic biomarker for human lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC)
por: Moin, Abu Tayab, et al.
Publicado: (2021)

Correlation between serum IL-1β and miR-144-3p as well as their prognostic values in LUAD and LUSC patients
por: Wu, Chen, et al.
Publicado: (2016)

NF-YA Overexpression in Lung Cancer: LUSC
por: Bezzecchi, Eugenia, et al.
Publicado: (2019)

Immune Subtypes in LUAD Identify Novel Tumor Microenvironment Profiles With Prognostic and Therapeutic Implications
por: Wang, Feng, et al.
Publicado: (2022)

A promising prognostic signature for lung adenocarcinoma (LUAD) patients basing on 6 hypoxia-related genes
por: Luo, Jie, et al.
Publicado: (2021)

PBK correlates with prognosis, immune escape and drug response in LUAD
por: Ma, Hongyu, et al.
Publicado: (2023)

NF-YA Overexpression in Lung Cancer: LUAD
por: Bezzecchi, Eugenia, et al.
Publicado: (2020)

Oxidative Stress-Related lncRNAs Are Potential Biomarkers for Predicting Prognosis and Immune Responses in Patients With LUAD
por: Sun, Xinti, et al.
Publicado: (2022)

TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment
por: Guo, Yanlin, et al.
Publicado: (2023)

STK24 Promotes Progression of LUAD and Modulates the Immune Microenvironment
por: Li, Yadong, et al.
Publicado: (2023)

Network pharmacology and bioinformatics analysis identifies potential therapeutic targets of Naringenin against COVID-19/LUSC
por: Wu, Wen-yu, et al.
Publicado: (2023)

Construction of an immune-related lncRNA signature as a novel prognosis biomarker for LUAD
por: Chen, Hang, et al.
Publicado: (2021)

m(6)A-related lncRNAs are potential biomarkers for predicting prognoses and immune responses in patients with LUAD
por: Xu, Feng, et al.
Publicado: (2021)

The Clinical Prediction Value of the Ubiquitination Model Reflecting the Immune Traits in LUAD
por: Che, Yinggang, et al.
Publicado: (2022)

A novel LUAD prognosis prediction model based on immune checkpoint-related lncRNAs
por: Liu, Yang, et al.
Publicado: (2022)

Multiple Omics Analysis of the Role of RBM10 Gene Instability in Immune Regulation and Drug Sensitivity in Patients with Lung Adenocarcinoma (LUAD)
por: Wu, Liusheng, et al.
Publicado: (2023)

A radiomics nomogram prediction for survival of patients with “driver gene-negative” lung adenocarcinomas (LUAD)
por: Guo, Qi-Kun, et al.
Publicado: (2023)

The antihypertensive felodipine shows synergistic activity with immune checkpoint blockade and inhibits tumor growth via NFAT1 in LUSC
por: Liang, Si-Yu, et al.
Publicado: (2023)

Multi-omics Data Analyses Construct TME and Identify the Immune-Related Prognosis Signatures in Human LUAD
por: Zhang, Yuwei, et al.
Publicado: (2020)

Upregulation of deubiquitinase PSMD14 in lung adenocarcinoma (LUAD) and its prognostic significance
por: Zhang, Ling, et al.
Publicado: (2020)

Dissecting the Immunological Profiles in NSD3-Amplified LUSC through Integrative Multi-Scale Analyses
por: Xu, Duo, et al.
Publicado: (2022)

miR-139-5p and miR-451a as a Diagnostic Biomarker in LUSC
por: Gao, Bo, et al.
Publicado: (2023)

RAGA prevents tumor immune evasion of LUAD by promoting CD47 lysosome degradation
por: Zhang, Lian, et al.
Publicado: (2023)

MDFI is a novel biomarker for poor prognosis in LUAD
por: Chen, Pengyu, et al.
Publicado: (2022)

MCM4 acts as a biomarker for LUAD prognosis
por: Tan, Yue, et al.
Publicado: (2023)

TAGAP expression influences CD4+ T cell differentiation, immune infiltration, and cytotoxicity in LUAD through the STAT pathway: implications for immunotherapy
por: Xu, Zhanyu, et al.
Publicado: (2023)

Membrane tension sensing molecule-FNBP1 is a prognostic biomarker related to immune infiltration in BRCA, LUAD and STAD
por: Wang, Zixuan, et al.
Publicado: (2022)

Characterizing the Copy Number Variation of Non-Coding RNAs Reveals Potential Therapeutic Targets and Prognostic Markers of LUSC
por: Ning, Jinfeng, et al.
Publicado: (2021)

Self-restricted circular RNA circSOX2 suppressed the malignant progression in SOX2-amplified LUSC
por: Liang, Yingkuan, et al.
Publicado: (2022)

Identification of Key Pathways and Genes Related to Immunotherapy Resistance of LUAD Based on WGCNA Analysis
por: Yu, Weina, et al.
Publicado: (2022)

Deubiquitinase UCHL5 is elevated and associated with a poor clinical outcome in lung adenocarcinoma (LUAD)
por: Zhang, Jieru, et al.
Publicado: (2020)

Single cell transcriptome revealed tumor associated antigen (TAA) profile in lung adenocarcinoma (LUAD)
por: Lv, Fang, et al.
Publicado: (2021)

A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD)
por: Al-Dherasi, Aisha, et al.
Publicado: (2021)

Pan-cancer landscape of CENPO and its underlying mechanism in LUAD
por: Shi, Tongdong, et al.
Publicado: (2023)

Genomic and immunogenomic analysis of three prognostic signature genes in LUAD
por: Feng, Hai-Ming, et al.
Publicado: (2023)

Establishment and validation of individualized clinical prognostic markers for LUAD patients based on autophagy-related genes
por: Fei, Yuchang, et al.
Publicado: (2022)

Heterogeneity of tumor immune microenvironment in malignant and metastatic change in LUAD is revealed by single-cell RNA sequencing
por: Wang, Haiqiang, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1htojoe982f09hnkrjlee475f1